ACCESS REALMONEY
Email This Article
Headlines & Perspectives
Imclone's Spot at the Podium May Be a Tip-Off It Has a Cancer Drug Hit
By
Adam Feuerstein
04/04/01 - 09:13 AM EDT
The biotech firm is expected to beat its rivals to filing a new drug application with regulators.
The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.
Sign up for our FREE newsletters now.
Keep on top of the market and the critical information you need to make more profitable investing decisions.
